logo GSK

Vaccines

We market over 25 vaccines worldwide to prevent potentially life-threatening or crippling illnesses such as hepatitis A, hepatitis B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza and bacterial meningitis.

The majority of our vaccine R&D activities are conducted at GlaxoSmithKline Biologicals in Rixensart, Belgium. Over 1300 of our research scientists are devoted to developing new vaccines and more cost-effective and convenient combination vaccines to prevent infections that cause serious medical problems worldwide.

We are also targeting therapeutic vaccines that may prevent relapse in cancer patients. The strength of our vaccine pipeline will provide opportunities for us to consistently deliver new vaccines for many years to come.

Here you will find the Patient Information Leaflets or Prescribing Information for our vaccines. Please note that this information is often specific to a country or region and is not intended to replace the advice of a qualified doctor.

Products are in various stages of approval around the world and may not be available in every country.

Trademark

Generic

ACWY Vaxmeningococcal polysaccharides serogroups A, C, W135 and Y
AmbirixHepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
Boostrixtetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed
CervarixHuman Papillomavirus vaccine (types 16, 18) - recombinant, adjuvanted, adsorbed
Engerix-BHepatitis B Vaccine (Recombinant)
FendrixHepatitis B (rDNA) vaccine (adjuvanted, adsorbed)
Fluarixinfluenza vaccine
FluLavalinfluenza vaccine
Havrixhepatitis A vaccine, inactivated
HepatyrixHepatitis A (inactivated, adsorbed) and Typhoid Polysaccharide vaccine
Hiberixhaemophilus B conjugate vaccine (tetanus toxoid conjugate)
Infanrixdiphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed
Infanrix IPVdiphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed)
Infanrix IPV + HIBdiphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) and Haemophilus influenzae serotype b conjugate vaccine (adsorbed)
Influenza A (H1N1) 2009 / Monovalent VaccineInfluenza A (H1N1) 2009 Monovalent Vaccine
Kinrixdiphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine
Menitorixcombined Haemophilus influenzae type b and Neisseria meningitidis group C (Hib-MenC) conjugate vaccines
Pandemrixinfluenza vaccine (split virion, inactivated)
Pediarixdiphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated poliovirus vaccine combined
Priorixmeasles, mumps and rubella vaccine (live attenuated virus)
Rotarixhuman rotavirus vaccine, live attenuated
SynflorixPneumococcal polysaccharide conjugate vaccine (adsorbed)
Twinrixcombined hepatitis A (inactivated virus) and hepatitis B vaccine (genetically derived surface antigen)
Typherixtyphoid vaccine (purified polysaccharide antigen)
Varilrixvaricella in healthy adults and adolescents

Back to top

GSK Health

Hospital doctor and nurse

A new product information website for healthcare professionals and the public in the UK

Research and development

Image of test tubes

Building a strong and diverse R&D pipeline

File formats

To view PDF documents you may need to install Adobe Reader. PDF links on this site open in a new tab.

For audio or video content you may need to install Windows Media Player.